BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24714149)

  • 1. Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines.
    Hernández V; Clofent J
    Ann Gastroenterol; 2012; 25(3):193-200. PubMed ID: 24714149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in inflammatory bowel disease.
    Potack J; Itzkowitz SH
    Gut Liver; 2008 Sep; 2(2):61-73. PubMed ID: 20485613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer in inflammatory bowel disease.
    Xie J; Itzkowitz SH
    World J Gastroenterol; 2008 Jan; 14(3):378-89. PubMed ID: 18200660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and Neoplasia of the Pouch in Inflammatory Bowel Disease.
    Khan F; Shen B
    Curr Gastroenterol Rep; 2019 Feb; 21(4):10. PubMed ID: 30815755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.
    Nieminen U; Jussila A; Nordling S; Mustonen H; Färkkilä MA
    Int J Cancer; 2014 Jan; 134(1):189-96. PubMed ID: 23797639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients.
    Gaidos JK; Bickston SJ
    Inflamm Bowel Dis; 2016 May; 22(5):1219-30. PubMed ID: 26926040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis.
    Imam MH; Eaton JE; Puckett JS; Loftus EV; Mathis KL; Gossard AA; Talwalkar JA; Lindor KD
    J Crohns Colitis; 2014 Oct; 8(10):1294-9. PubMed ID: 24768559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
    Galanopoulos M; Tsoukali E; Gkeros F; Vraka M; Karampekos G; Matzaris GJ
    World J Gastrointest Endosc; 2018 Oct; 10(10):250-258. PubMed ID: 30364842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
    Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Imam MH; Thackeray EW; Lindor KD
    Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.